Group 6 Copy 228
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    How good are North American mosquitoes at spreading Zika virus?

    Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...

    Mosquitoes as Flying Syringes: The Solution to Rapid Zika Monitoring

    Yes, mosquitoes are flying syringes! They sample human blood as a normal part of their life cycle. We can...

    Backer Badge Funded